ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

TOI Oncology Institute Inc

0.666
-0.0072 (-1.07%)
최종 업데이트: 22:44:21
15분 지연
기업명 주식 심볼 시장 주식 타입
Oncology Institute Inc TOI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0072 -1.07% 0.666 22:44:21
개장가 저가 고가 종가 전일 종가
0.6859 0.662 0.6959 0.6732
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/05/202405:05GLOBEThe Oncology Institute Reports First Quarter 2024 Financial..
08/05/202405:05GLOBEThe Oncology Institute to Participate in Panel Discussion at..
23/04/202421:00GLOBEThe Oncology Institute Announces First Quarter 2024 Earnings..
08/04/202421:00GLOBEJordan McInerney Appointed as Chief Development Officer of..
04/04/202421:00GLOBEThe Oncology Institute and Healthly Forge Strategic Alliance..
28/03/202405:05GLOBEThe Oncology Institute Reports Fourth Quarter and Full Year..
14/03/202421:09GLOBEMaxHealth & The Oncology Institute Expand Value-Based Care..
06/03/202422:00GLOBEThe Oncology Institute Announces Fourth Quarter and Full..
28/02/202406:05GLOBEThe Oncology Institute to Participate at Upcoming Investor..
20/02/202422:00GLOBECarrum Health and The Oncology Institute Partner on Breast..
25/01/202422:00GLOBEWellBe Senior Medical Partners with The Oncology Institute..
20/01/202406:00EDGAR2Form 144 - Report of proposed sale of securities
29/12/202307:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202307:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202307:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202309:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:00GLOBEThe Oncology Institute Expands its Specialty Medication..
23/11/202311:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202310:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202310:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202309:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202307:27EDGAR2Form 144 - Report of proposed sale of securities
17/11/202306:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202305:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202308:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202307:17EDGAR2Form 144 - Report of proposed sale of securities
09/11/202306:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:41EDGAR2Form 8-K - Current report
09/11/202306:05GLOBEThe Oncology Institute Reports Third Quarter 2023 Financial..
18/10/202321:03GLOBEThe Oncology Institute Announces Third Quarter 2023 Earnings..
12/10/202305:05GLOBEThe Oncology Institute Names Jeremy Castle as Chief..
27/09/202305:05GLOBEThe Oncology Institute Executive Leaders to Present at the..
18/09/202321:00EDGAR2Form 8-K - Current report
18/09/202321:00GLOBEThe Oncology Institute Regains Compliance with Nasdaq..
08/09/202303:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/09/202305:07EDGAR2Form 8-K - Current report
02/09/202305:00EDGAR2Form 8-K - Current report
31/08/202304:04EDGAR2Form 8-K - Current report
11/08/202306:15EDGAR2Form 8-K - Current report
10/08/202305:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202321:10GLOBEAmbience Healthcare and The Oncology Institute (TOI) Partner..
09/08/202305:40GLOBEThe Oncology Institute Reports Second Quarter 2023 Financial..
31/07/202321:00GLOBEThe Oncology Institute Partners with House Rx to Accelerate..
18/07/202321:00GLOBEThe Oncology Institute Announces Second Quarter 2023..
12/06/202319:00GLOBEThe Oncology Institute Announces Leadership Transition
09/06/202321:00GLOBEThe Oncology Institute (TOI) and Massive Bio Forge..
07/06/202321:00GLOBEThe Oncology Institute to Open Project Southland
31/05/202321:01GLOBEThe Oncology Institute Featured on Four Abstracts at ASCO..
31/05/202321:00GLOBEThe Oncology Institute to Participate at Upcoming Investor..